Daljeet Kohli of IndiaNivesh Securities gave solid reasoning when he recommended J. B. Chemicals. Its margins are on the uptick thanks to the new DPCO 2013 and it is quoting at cheap valuations. You have the benefit of growth with a nice margin of safety, he said.
Since he recommended the stock at Rs. 94 in late October 2013, the stock has given a return of 44% at the CMP of Rs. 137. That’s a fabulous return for a 3 month investment by any standards.
Sharekhan recommended J. B. Chemicals in December 2013 for a target of Rs. 189.
Now, if you haven’t got a chunk of J. B. Chemicals in your portfolio, you need to seriously consider it. After all, if JB Chemicals becomes another Alembic Pharma, you don’t want to be left behind, do you?
I already have a nice little chunk of JB Chem in my portfolio but I am game for picking up more if the price slides a bit.
I also have the behemoth Sun Pharma in my portfolio. It is an expensive stock but you never go wrong with quality stocks like that.
According to Elara Capital, mid-cap pharma stocks is where the action is going to be in 2014 (apart from Info Tech stocks).
You should also check out Daljeet’s other stock picks for the year 2014. All of them are of top notch companies, quoting at reasonable valuations. You really cannot go wrong with sensible stocks over the long-term.
If you are looking for other stock ideas, you should see ICICI-Direct’s Model Stock Portfolio which gave an incredible return of 36% in 2013.
If you want more inspiration, you should see Angel Broking’s list of the best multibagger stocks of 2013. It will blow your mind!
Focus in U.S market and strong balance sheet is definitely added advantage.
JB Chemicals is probably the best pick in Pharma,re-rating upsides could be huuge.